Anticancer activities of two sesquiterpene lactones, millerenolide and thieleanin isolated from Viguiera sylvatica and Decachaeta thieleana

Fitoterapia

Volumn 79, Issue 6, 2008, Pages 428-432

  Taylor, Peter G ^a   Dupuy Loo, Omar A ^b   Bonilla, José A ^c   Murillo, Renato ^c  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

^b UNIVERSIDAD DE PANAMÁ   (Panama)

^c UNIVERSIDAD DE COSTA RICA   (Costa Rica)

Author keywords

B16 BL6 melanoma; Decachaeta thieleana; Millerenolide; Thieleanin; Viguiera sylvatica

Indexed keywords

AJOENE; ANTINEOPLASTIC AGENT; DECACHAETA THIELEANA EXTRACT; MILLERENOLIDE; PLANT EXTRACT; SESQUITERPENE LACTONE DERIVATIVE; THIELEANIN; UNCLASSIFIED DRUG; VIGUIERA SYLVATICA EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL VIABILITY; CONTROLLED STUDY; DECACHAETA THIELEANA; DRUG CYTOTOXICITY; DRUG ISOLATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MALE; MEDICINAL PLANT; MELANOMA; MOUSE; NONHUMAN; ONCOGENE NEU; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; TUMOR GROWTH; VIGUIERA SYLVATICA;

MUS; VIGUIERA;

EID: 49849084093     PISSN: 0367326X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fitote.2007.07.019     Document Type: Article

References (21)

1. Willuhn G. Phytomedicines of Europe. Chemistry and biological activity (1998), American Chemical Society, Washington DC 118
2. Cho J.Y., Park J., Yoo E.S., Baik K.U., Jung J.H., Lee J., et al. Planta Med 64 (1998) 594
3. Humar M., García-Piñeres A.J., Merfort I., and Castro V. Biochem Pharmacol 65 (2003) 1551
4. Dirsch V.M., Stuppner H., and Vollmar A.M. Cancer Res 61 (2001) 5817
5. Bocca C., Gabriel L., Bozzo F., and Miglietta A. Chem Biol Interact 147 (2004) 79
6. Park S.H., Choi S.U., Lee C.O., Yoo S.E., Yoon S.K., Kim Y.K., et al. Planta Med 67 (2001) 358
7. Oh G.S., Pae H.O., Chung H.T., Kwon J.W., Lee J.H., Kwon T.O., et al. Immunopharmacol Immunotoxicol 26 (2004) 163
8. Ross J.J., Arnason J.T., and Birnboim H.C. Planta Med 65 (1999) 126
9. Zhang S., Ong C.N., and Shen H.M. Cancer Lett 211 (2004) 175
10. Nakshatri H., Bhat-Nakshatri P., and Rice S.E. Oncogene 23 (2004) 7330
11. Sweeney C.J., Mehrotra S., Badve S., Sadaria M.R., Kumar S., Shortle N.H., et al. Mol Cancer Ther 4 (2005) 1004
12. Won Y.K., Ong C.N., Shen H.M., and Shi X. Carcinogenesis 25 (2004) 1449
13. Barkett M., and Gilmore T.D. Oncogene 18 (1999) 6910
14. Baldwin A.S. J Clin Invest 107 (2001) 241
15. Yamamoto Y., and Gaynor R.B. J Clin Invest 107 (2001) 135
16. Bork P.M., Schmitz M.L., Kuhnt M., Escher C., and Heinrich M. FEBS Lett 402 (1997) 85
17. Rüngeler P., Merfort I., Castro V., Mora G., Gören N., Vichnewski W., et al. Bioorg Med Chem 7 (1999) 2343
18. Castro V., Murillo R., Hernandez E., Rüngeler P., Merfort I., Mora G., et al. Phytochemistry 53 (2000) 257
19. Hudziak R.M., Schlessinger J., and Ullrich A. Proc Natl Acad Sci U S A 84 (1987) 7159
20. Taylor P., Noriega R., Farah C., Abad M.J., Arsenak M., and Apitz R. Cancer Lett 239 (2006) 298
21. Beekman A.C., Woerdenbag H.J., Van Uden W., Pras N., Wikström H.V., Konings A.W.T., et al. J Nat Prod 60 (1997) 252